Amulet Capital Partners has sold OPEN Health to Astorg, according to a news release.
OPEN Health, established in 2011 and with several U.S. offices, is a global provider of scientific communications and market access services to the pharmaceutical industry.
Amulet, based in Greenwich, Conn., is a middle market private equity investment firm…
WindRose Health Investors has acquired Ganse Apothecary, according to a news release.
Ganse, based in Lancaster, Pa., is a closed-door, long-term care and specialty pharmacy. Founded in 1971, the pharmacy supports patients suffering from severe and persistent mental illness and intellectual and developmental disabilities.
WindRose, based in New York, pursues control equity…
During the pandemic, audio-only telehealth was a critical tool to provide care to populations that could not use video during telehealth sessions, due to factors such as lack of financial resources, disability or lack of sufficient broadband coverage.
New HHS guidance outlines steps covered entities should take to ensure that their audio-only telehealth practices are…
This article was originally published in “The Review of Securities & Commodities Regulation,” Vol. 55 No. 13, July 20, 2022.
An Ohio Court of Appeals recently weighed in on the proper protocols one must take in order to successfully assert one’s Fifth Amendment Constitutional Right against self-incrimination in relation to a discovery request in a civil case that may have incriminating affects in an ongoing anti-kickback statute (AKS) investigation. The Fifth Amendment of the United States Constitution reads in pertinent part that, “No person shall . . . be compelled in any criminal case to be a witness against himself.” In Marilyn Williams-Salmon v Deepak Raheja, M.D., the court ruled that to assert the Fifth Amendment in a civil case which in turn would have shielding effects in an ongoing AKS prosecution, one must, “answer with sufficient specificity to provide the trial court with a record upon which to decide whether the privilege has been properly asserted to each [request].” The court found that because the defendants did not provide the requisite specificity, the court ordered that the defendants must respond to the civil requests.
Veritas Capital has acquired Coronis Health, according to Axios.
Coronis, based in Sykesville, Md., is a healthcare revenue cycle management company. Founded in 2015, the company plays across several industries, including pathology, behavioral health, hospitals, surgery centers and primary care and specialty physicians.
Veritas, based in New York, is a private equity…
The Assistant Attorney General and head of the Department of Justice’s Criminal Division recently sat for an interview with the Wall Street Journal where he provided important insight into the Department’s increased focus on corporate compliance.
Drawing on his experience in the U.S. Attorney’s office and as the Chief Compliance Officer at a Fortune 500 company, Polite described the importance of “prevention” and why investment in the preventative aspects of corporate compliance programs will be crucial to the Department’s overall efforts to fight corporate misconduct. Recognizing the Department is well situated to expand on its current policies, the Assistant Attorney General underscored the realities and need for a wider approach in halting future violations: “Even if we tried to prosecute every instance of corporate wrongdoing that we can possibly achieve, it still wouldn’t be enough…. We have to invest in prevention as a department, and, frankly, as a society.”
Conlan v. Alternative Asset Management Acquisition Corp. was filed in the United States District Court for the District of Colorado on June 14, 2022, claiming Defendants illegally profited from violations of securities laws. The complaint seeks to avoid multiple actual and constructive fraudulent transfers.
Plaintiff is court-appointed substitute receiver Mark Conlan (the “Receiver”), serving as representative and fiduciary of the creditors of the defendants named in the action brought by the Securities and Exchange Commission (“SEC”) captioned United States Securities and Exchange Commission v. Mediatrix Capital Inc., et al., No. 1:19-cv-02594-RM-SKC (the “SEC Action”). Defendants Alternative Asset Management Acquisition Corp., Autumn Gold Service, Crown Financial Services, Crown Private Limited, Marta Nystrom, Mercury Alternative Fund, Patricia Velcich, Phenom Ventures, Ritossa Investment Holding Ltd., and Y Man Investments are brokers that allegedly received funds in connection with the foreign currency trading scheme at issue in the SEC Action.
The SEC Action names individuals Michael A. Young, Michael S. Stewart, and Bryant E. Sewall and entities Mediatrix Capital Inc. (“Mediatrix”), Blue Isle Markets Inc., and Blue Isle Markets Ltd. (collectively, the “Receivership Defendants”).
TA Associates will make a growth investment in Intelerad, according to a news release.
Intelerad, with its U.S. headquarters in Raleigh, N.C., is a provider of enterprise medical imaging solutions. Founded in 1999, provides software and enterprise workflow solutions to healthcare providers worldwide, including radiology groups, outpatient imaging centers, hospitals and healthcare systems.…
On July 8, 2022, the U.S. Department of Justice announced a $9 million
settlement with federal government contractor Aerojet Rocketdyne, Inc. for
alleged violations of the False Claims Act in a case pending in the Eastern
District of California. The settlement results from alleged false
statements by Aerojet related to compliance with Department of Defense…
